Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 114

    1.

    Anesthesiologists with substance use disorders: a 5-year outcome study from 16 state physician health programs.

    Skipper GE, Campbell MD, Dupont RL.

    Anesth Analg. 2009 Sep;109(3):891-6.PMID: 19690263 [PubMed - indexed for MEDLINE]Related articles

    2.

    National Institute on Drug Abuse at its first 35 years.

    Dupont RL.

    Drug Alcohol Depend. 2009 Jun 8. [Epub ahead of print] No abstract available. PMID: 19515517 [PubMed - as supplied by publisher]Related articles

    3.

    How are addicted physicians treated? A national survey of Physician Health Programs.

    DuPont RL, McLellan AT, Carr G, Gendel M, Skipper GE.

    J Subst Abuse Treat. 2009 Jul;37(1):1-7.PMID: 19482236 [PubMed - indexed for MEDLINE]Related articles

    4.

    Anesthesiologists returning to work after substance abuse treatment.

    Skipper GE, DuPont RL.

    Anesthesiology. 2009 Jun;110(6):1422-3; author reply 1426-8. No abstract available. PMID: 19461306 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Setting the standard for recovery: Physicians' Health Programs.

    DuPont RL, McLellan AT, White WL, Merlo LJ, Gold MS.

    J Subst Abuse Treat. 2009 Mar;36(2):159-71.PMID: 19161896 [PubMed - indexed for MEDLINE]Related articles

    6.

    Five year outcomes in a cohort study of physicians treated for substance use disorders in the United States.

    McLellan AT, Skipper GS, Campbell M, DuPont RL.

    BMJ. 2008 Nov 4;337:a2038. doi: 10.1136/bmj.a2038.PMID: 18984632 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Addiction in medicine.

    DuPont RL.

    Trans Am Clin Climatol Assoc. 2008;119:227-41. No abstract available. PMID: 18596844 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Characteristics and motives of college students who engage in nonmedical use of methylphenidate.

    Dupont RL, Coleman JJ, Bucher RH, Wilford BB.

    Am J Addict. 2008 May-Jun;17(3):167-71.PMID: 18463991 [PubMed - indexed for MEDLINE]Related articles

    9.

    School-based administration of ADHD drugs decline, along with diversion, theft, and misuse.

    Dupont RL, Bucher RH, Wilford BB, Coleman JJ.

    J Sch Nurs. 2007 Dec;23(6):349-52.PMID: 18052521 [PubMed - indexed for MEDLINE]Related articles

    10.

    Opioid treatment for chronic back pain and its association with addiction.

    DuPont RL, Graham NA, Gold MS.

    Ann Intern Med. 2007 Sep 4;147(5):349; author reply 349-50. No abstract available. PMID: 17785497 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Symptoms of ADHD or marijuana use?

    Graham NA, DuPont RL, Gold MS.

    Am J Psychiatry. 2007 Jun;164(6):973; author reply 973-4. No abstract available. PMID: 17541060 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Comorbidity and "self-medication".

    DuPont RL, Gold MS.

    J Addict Dis. 2007;26 Suppl 1:13-23.PMID: 19283971 [PubMed - indexed for MEDLINE]Related articles

    13.

    Abuse-resistant drug delivery.

    DuPont RL, Bensinger PB.

    Pediatr Ann. 2006 Aug;35(8):587-8, 590, 592.PMID: 16986453 [PubMed - indexed for MEDLINE]Related articles

    14.

    Prescription stimulant abuse.

    DuPont RL.

    Pediatr Ann. 2006 Aug;35(8):534, 536-7.PMID: 16986446 [PubMed - indexed for MEDLINE]Related articles

    15.

    Physicians and drug screening.

    Gold MS, Frost-Pineda K, Goldberger BA, DuPont RL.

    J Adolesc Health. 2006 Aug;39(2):154-5; author reply 155. No abstract available. PMID: 16857524 [PubMed - indexed for MEDLINE]Related articles

    16.

    Can drug design inhibit abuse?

    Coleman JJ, Bensinger PB, Gold MS, Smith DE, Bianchi RP, DuPont RL.

    J Psychoactive Drugs. 2005 Dec;37(4):343-62. Review.PMID: 16480162 [PubMed - indexed for MEDLINE]Related articles

    17.

    [Attention-Deficit Hyperactivity Disorder]

    DuPont RL.

    Essent Psychopharmacol. 2005;6(5):iv. No abstract available. PMID: 16222908 [PubMed - indexed for MEDLINE]Related articles

    18.

    Conversation with Robert L. DuPont.

    DuPont RL.

    Addiction. 2005 Oct;100(10):1402-11. No abstract available. PMID: 16185202 [PubMed - indexed for MEDLINE]Related articles

    19.

    Benzodiazepines and anxiety disorders: a review for the practicing physician.

    Michael Kaplan E, DuPont RL.

    Curr Med Res Opin. 2005 Jun;21(6):941-50. Review.PMID: 15969894 [PubMed - indexed for MEDLINE]Related articles

    20.

    A commentary on "Urine testing in methadone maintenance treatment: applications and limitations". Thinking outside the urine cup.

    DuPont RL.

    J Subst Abuse Treat. 2003 Sep;25(2):67-8. No abstract available. PMID: 14629986 [PubMed - indexed for MEDLINE]Related articles

    21.

    Biology and the environment-rethinking demand reduction.

    DuPont RL.

    J Addict Dis. 1999;18(4):121-38. No abstract available. PMID: 10631969 [PubMed - indexed for MEDLINE]Related articles

    22.

    Impairment in pure and comorbid generalized anxiety disorder and major depression at 12 months in two national surveys.

    Kessler RC, DuPont RL, Berglund P, Wittchen HU.

    Am J Psychiatry. 1999 Dec;156(12):1915-23.PMID: 10588405 [PubMed - indexed for MEDLINE]Related articlesFree article

    23.

    Efficacy, safety, and tolerability of venlafaxine extended release and buspirone in outpatients with generalized anxiety disorder.

    Davidson JR, DuPont RL, Hedges D, Haskins JT.

    J Clin Psychiatry. 1999 Aug;60(8):528-35.PMID: 10485635 [PubMed - indexed for MEDLINE]Related articles

    24.

    Twelve-step and mutual-help programs for addictive disorders.

    Chappel JN, DuPont RL.

    Psychiatr Clin North Am. 1999 Jun;22(2):425-46.PMID: 10385942 [PubMed - indexed for MEDLINE]Related articles

    25.

    The origins of the Minnesota model of addiction treatment--a first person account.

    Anderson DJ, McGovern JP, DuPont RL.

    J Addict Dis. 1999;18(1):107-14.PMID: 10234566 [PubMed - indexed for MEDLINE]Related articles

    26.

    Examining the debate on the use of medical marijuana.

    DuPont RL.

    Proc Assoc Am Physicians. 1999 Mar-Apr;111(2):166-72. Review.PMID: 10220812 [PubMed - indexed for MEDLINE]Related articles

    27.

    Addiction: a new paradigm.

    DuPont RL.

    Bull Menninger Clin. 1998 Spring;62(2):231-42.PMID: 9604518 [PubMed - indexed for MEDLINE]Related articles

    28.

    Violence and drugs.

    DuPont RL.

    J Psychoactive Drugs. 1997 Oct-Dec;29(4):303-5. Review. No abstract available. PMID: 9460023 [PubMed - indexed for MEDLINE]Related articles

    29.

    Medicinal marijuana?

    DuPont RL.

    N Engl J Med. 1997 Apr 17;336(16):1184; author reply 1186-7. No abstract available. PMID: 9102565 [PubMed - indexed for MEDLINE]Related articles

    30.

    Panic disorder and addiction: the clinical issues of comorbidity.

    DuPont RL.

    Bull Menninger Clin. 1997 Spring;61(2 Suppl A):A54-65.PMID: 9149465 [PubMed - indexed for MEDLINE]Related articles

    31.

    Harm reduction and decriminalization in the United States: a personal perspective.

    DuPont RL.

    Subst Use Misuse. 1996 Dec;31(14):1929-45; discussion 1947-72.PMID: 8969018 [PubMed - indexed for MEDLINE]Related articles

    32.

    Economic costs of anxiety disorders.

    DuPont RL, Rice DP, Miller LS, Shiraki SS, Rowland CR, Harwood HJ.

    Anxiety. 1996;2(4):167-72.PMID: 9160618 [PubMed - indexed for MEDLINE]Related articles

    33.

    Drug legalization, harm reduction, and drug policy.

    DuPont RL, Voth EA.

    Ann Intern Med. 1995 Sep 15;123(6):461-5.PMID: 7639447 [PubMed - indexed for MEDLINE]Related articlesFree article

    34.

    Economic costs of obsessive-compulsive disorder.

    DuPont RL, Rice DP, Shiraki S, Rowland CR.

    Med Interface. 1995 Apr;8(4):102-9. Review.PMID: 10141765 [PubMed - indexed for MEDLINE]Related articles

    35.

    Drug testing by urine and hair analysis: complementary features and scientific issues.

    DuPont RL, Baumgartner WA.

    Forensic Sci Int. 1995 Jan 5;70(1-3):63-76. Review.PMID: 7860037 [PubMed - indexed for MEDLINE]Related articles

    36.

    Random drug tests at work: the probability of identifying frequent and infrequent users of illicit drugs.

    DuPont RL, Griffin DW, Siskin BR, Shiraki S, Katze E.

    J Addict Dis. 1995;14(3):1-17.PMID: 8555274 [PubMed - indexed for MEDLINE]Related articles

    37.

    Anxiety and addiction: a clinical perspective on comorbidity.

    DuPont RL.

    Bull Menninger Clin. 1995 Spring;59(2 Suppl A):A53-72. Review.PMID: 7795572 [PubMed - indexed for MEDLINE]Related articles

    38.

    The war on drugs.

    DuPont RL.

    N Engl J Med. 1994 Jul 14;331(2):128; author reply 128-9. No abstract available. PMID: 8208259 [PubMed - indexed for MEDLINE]Related articles

    39.

    The treatment of anxiety: realistic expectations and risks posed by controlled substances.

    DuPont RL, DuPont CM.

    J Law Med Ethics. 1994 Fall;22(3):206-14. Review. No abstract available. PMID: 7749475 [PubMed - indexed for MEDLINE]Related articles

    40.

    Benzodiazepines, addiction, and public policy.

    DuPont RL.

    N J Med. 1993 Nov;90(11):823-6.PMID: 7903804 [PubMed - indexed for MEDLINE]Related articles

    41.

    Alprazolam and benzodiazepine dependence.

    Sellers EM, Ciraulo DA, DuPont RL, Griffiths RR, Kosten TR, Romach MK, Woody GE.

    J Clin Psychiatry. 1993 Oct;54 Suppl:64-75; discussion 76-7. Review.PMID: 8262891 [PubMed - indexed for MEDLINE]Related articles

    42.

    Discontinuation of alprazolam after long-term treatment of panic-related disorders.

    DuPont RL, Swinson RP, Ballenger JC, Burrows GD, Noyes R, Rubin RT, Rifkin A, Pecknold JC.

    J Clin Psychopharmacol. 1992 Oct;12(5):352-4.PMID: 1479053 [PubMed - indexed for MEDLINE]Related articles

    43.

    Depressant substances in adolescent medicine.

    DuPont RL, Saylor KE.

    Pediatr Rev. 1992 Oct;13(10):381-6. Review.PMID: 1470572 [PubMed - indexed for MEDLINE]Related articles

    44.

    Suffering in addiction: alcoholism and drug dependence.

    DuPont RL, McGovern JP.

    NLN Publ. 1992 Mar;(15-2461):155-201. No abstract available. PMID: 1287582 [PubMed - indexed for MEDLINE]Related articles

    45.

    The high way: driving under influences other than alcohol.

    Saylor KE, DuPont RL, Brown H.

    JAMA. 1992 Feb 5;267(5):652. No abstract available. PMID: 1472170 [PubMed - indexed for MEDLINE]Related articles

    46.

    Responsible prescribing of controlled substances.

    Voth EA, Dupont RL, Voth HM.

    Am Fam Physician. 1991 Nov;44(5):1673-8. Review.PMID: 1950964 [PubMed - indexed for MEDLINE]Related articles

    47.

    Student assistance programs: an important approach to drug abuse prevention.

    McGovern JP, DuPont RL.

    J Sch Health. 1991 Aug;61(6):260-4. No abstract available. PMID: 1956173 [PubMed - indexed for MEDLINE]Related articles

    48.

    Thinking about stopping treatment for panic disorder.

    DuPont RL.

    J Clin Psychiatry. 1990 Dec;51 Suppl A:38-45. Review.PMID: 2258376 [PubMed - indexed for MEDLINE]Related articles

    49.

    Medicines and drug testing in the workplace.

    DuPont RL.

    J Psychoactive Drugs. 1990 Oct-Dec;22(4):451-9. Review.PMID: 2096190 [PubMed - indexed for MEDLINE]Related articles

    50.

    Benzodiazepines in a health-catalog product.

    DuPont RL, Bogema SC.

    JAMA. 1990 Aug 8;264(6):695. No abstract available. PMID: 2374271 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Search details

    » See more...